Alpine Immune Sciences Stock Return On Equity
| ALPNDelisted Stock | USD 7.90 0.00 0.00% |
Alpine Immune Sciences fundamentals help investors to digest information that contributes to Alpine Immune's financial success or failures. It also enables traders to predict the movement of Alpine Stock. The fundamental analysis module provides a way to measure Alpine Immune's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alpine Immune stock.
Alpine |
Alpine Immune Sciences Company Return On Equity Analysis
Alpine Immune's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Alpine Immune Return On Equity | -0.15 |
Most of Alpine Immune's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alpine Immune Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Alpine Immune Sciences has a Return On Equity of -0.1467. This is 99.39% lower than that of the Biotechnology sector and 99.6% lower than that of the Health Care industry. The return on equity for all United States stocks is 52.68% lower than that of the firm.
Alpine Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alpine Immune's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alpine Immune could also be used in its relative valuation, which is a method of valuing Alpine Immune by comparing valuation metrics of similar companies.Alpine Immune is currently under evaluation in return on equity category among its peers.
Alpine Fundamentals
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.1 | ||||
| Profit Margin | (0.65) % | ||||
| Operating Margin | (3.23) % | ||||
| Current Valuation | 4.16 B | ||||
| Shares Outstanding | 68.6 M | ||||
| Shares Owned By Insiders | 4.60 % | ||||
| Shares Owned By Institutions | 99.46 % | ||||
| Number Of Shares Shorted | 3.89 M | ||||
| Price To Earning | (32.69) X | ||||
| Price To Book | 12.87 X | ||||
| Price To Sales | 71.68 X | ||||
| Revenue | 58.88 M | ||||
| Gross Profit | (40.18 M) | ||||
| EBITDA | (43.67 M) | ||||
| Net Income | (32.18 M) | ||||
| Cash And Equivalents | 167.86 M | ||||
| Cash Per Share | 5.52 X | ||||
| Total Debt | 9.91 M | ||||
| Debt To Equity | 0.17 % | ||||
| Current Ratio | 2.75 X | ||||
| Book Value Per Share | 5.08 X | ||||
| Cash Flow From Operations | (79.01 M) | ||||
| Short Ratio | 0.96 X | ||||
| Earnings Per Share | (0.64) X | ||||
| Target Price | 62.0 | ||||
| Number Of Employees | 142 | ||||
| Beta | 0.97 | ||||
| Market Capitalization | 4.46 B | ||||
| Total Asset | 381.81 M | ||||
| Retained Earnings | (256.14 M) | ||||
| Working Capital | 288.05 M | ||||
| Current Asset | 25.53 M | ||||
| Current Liabilities | 3.39 M | ||||
| Net Asset | 381.81 M |
About Alpine Immune Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alpine Immune Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alpine Immune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alpine Immune Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Alpine Stock
If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |